Utilize este identificador para referenciar este registo:
http://hdl.handle.net/10773/33666
Título: | Genetic risk for covid-19 outcomes in COPD |
Autor: | Marçalo, Rui Neto, Sonya Pinheiro, Miguel Rodrigues, Ana Sousa, Nuno Santos, Manuel Simão, Paula Valente, Carla Andrade, Lília Marques, Alda Moura, Gabriela |
Palavras-chave: | COPD COVID-19 Genetic |
Data: | 5-Set-2021 |
Editora: | European Respiratory Society |
Resumo: | There is strong individual variability in both susceptibility and clinical response to covid-19 infection. People with chronic obstructive pulmonary disease (COPD) constitute one of covid-19 risk groups for poor outcomes upon infection. This study contributes to unveil the underlying reasons for such outcomes by looking at the genetic background of people with COPD. 255 people with COPD (66±9y; 72%♂; FEV1 53.01±20.31pp) and 243 controls (67±10y; 80%♂; FEV1 100.46±19.19pp) were clinically characterized and genotyped using saliva samples. Covid-19 associated SNPs from the literature (susceptibility: rs286914/rs12329760; severity: rs657152/rs11385942) were assessed and their allelic frequencies used to calculate the probability of having multiple risk alleles in both groups. Polygenic risk analysis was also conducted. No differences in genetic risk for covid-19 susceptibility or severity were found between groups (all p-values > 0.01), either considering individual risk alleles, allelic combinations or polygenic risk scores (Fig. 1). These results suggest a low genetic contribution for the poor covid-19 outcomes observed in people with COPD. |
Peer review: | yes |
URI: | http://hdl.handle.net/10773/33666 |
DOI: | 10.1183/13993003.congress-2021.PA670 |
ISSN: | 0903-1936 |
Aparece nas coleções: | ESSUA - Comunicações DCM - Comunicações IBIMED - Comunicações Lab3R - Comunicações |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Abstract ERS COPD study.pdf | 133.56 kB | Adobe PDF | Ver/Abrir |
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.